You are reviewing a newly published randomized controlled trial evaluating a novel oral anticoagulant for stroke prevention. The pharmaceutical company has provided several documents summarizing the findings. Match each excerpted statement from the trial's methodology, results, and promotional materials to the epidemiological or statistical concept it best describes.
- The analysis included all participants in the groups to which they were originally randomized, regardless of protocol violations or treatment discontinuation.Intention-to-treat analysis
- The study was calculated to have an 80% probability of detecting a true difference in the primary outcome between the two treatment arms, should one exist.Statistical power
- The drug advertisement prominently claims a '33% decrease in stroke risk', derived from an event rate of 2% in the treatment group versus 3% in the placebo group.Relative risk reduction
- The trial's primary efficacy measure was defined as the first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke.Composite endpoint
- The study design aimed to demonstrate that the new oral anticoagulant is not unacceptably worse than the standard of care by a predefined margin.Non-inferiority design
Answer
The excerpts correctly match to Intention-to-treat analysis (Excerpt 1), Statistical power (Excerpt 2), Relative risk reduction (Excerpt 3), Composite endpoint (Excerpt 4), and Non-inferiority design (Excerpt 5).
Each excerpt accurately defines a core biostatistical concept required for evaluating clinical trials. ITT prevents attrition bias, power prevents Type II errors, RRR contextualizes the magnitude of effect relative to baseline risk, composite endpoints increase event rates for analysis, and non-inferiority designs evaluate if a drug is an acceptable alternative to standard care.
Step-by-Step Solution
Key Concept
Accurate medical literature and drug advertisement interpretation requires recognizing epidemiological trial designs, statistical metrics, and how data presentation can influence clinical perception.